Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Incidence of cytomegalovirus (CMV) viremia during Campath-1H therapy for relapsed/refractory chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (PLL). Cao, T. M., Nguyen, D. D., Dugan, K., Starcher, S. A., Fechter, R. L., Coutre, S. E. AMER SOC HEMATOLOGY. 2001: 366A–366A
View details for Web of Science ID 000172134101544